These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 1735524)

  • 1. Prognostic features and role of liver transplantation in severe corticosteroid-treated autoimmune chronic active hepatitis.
    Sanchez-Urdazpal L; Czaja AJ; van Hoek B; Krom RA; Wiesner RH
    Hepatology; 1992 Feb; 15(2):215-21. PubMed ID: 1735524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and prognostic implications of HLA B8 in corticosteroid-treated severe autoimmune chronic active hepatitis.
    Czaja AJ; Rakela J; Hay JE; Moore SB
    Gastroenterology; 1990 Jun; 98(6):1587-93. PubMed ID: 2338197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors.
    Donaldson PT; Doherty DG; Hayllar KM; McFarlane IG; Johnson PJ; Williams R
    Hepatology; 1991 Apr; 13(4):701-6. PubMed ID: 2010165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis.
    Czaja AJ; Cassani F; Cataleta M; Valentini P; Bianchi FB
    Hepatology; 1996 Nov; 24(5):1068-73. PubMed ID: 8903377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis.
    Czaja AJ; Strettell MD; Thomson LJ; Santrach PJ; Moore SB; Donaldson PT; Williams R
    Hepatology; 1997 Feb; 25(2):317-23. PubMed ID: 9021941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of corticosteroids for the treatment of severe and fulminant forms of autoimmune hepatitis.
    Ichai P; Duclos-Vallée JC; Guettier C; Hamida SB; Antonini T; Delvart V; Saliba F; Azoulay D; Castaing D; Samuel D
    Liver Transpl; 2007 Jul; 13(7):996-1003. PubMed ID: 17370335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune features as determinants of prognosis in steroid-treated chronic active hepatitis of uncertain etiology.
    Czaja AJ; Davis GL; Ludwig J; Baggenstoss AH; Taswell HF
    Gastroenterology; 1983 Sep; 85(3):713-7. PubMed ID: 6192038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence against hepatitis viruses as important causes of severe autoimmune hepatitis in the United States.
    Czaja AJ; Carpenter HA; Santrach PJ; Moore SB; Taswell HF; Homburger HA
    J Hepatol; 1993 Jul; 18(3):342-52. PubMed ID: 8228128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antinuclear antibodies and patterns of nuclear immunofluorescence in type 1 autoimmune hepatitis.
    Czaja AJ; Cassani F; Cataleta M; Valentini P; Bianchi FB
    Dig Dis Sci; 1997 Aug; 42(8):1688-96. PubMed ID: 9286235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The nature and prognosis of severe cryptogenic chronic active hepatitis.
    Czaja AJ; Carpenter HA; Santrach PJ; Moore SB; Homburger HA
    Gastroenterology; 1993 Jun; 104(6):1755-61. PubMed ID: 8500735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Features associated with treatment failure in type 1 autoimmune hepatitis and predictive value of the model of end-stage liver disease.
    Montano-Loza AJ; Carpenter HA; Czaja AJ
    Hepatology; 2007 Oct; 46(4):1138-45. PubMed ID: 17668882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of autoantibodies to soluble liver antigen in autoimmune hepatitis.
    Kanzler S; Weidemann C; Gerken G; Löhr HF; Galle PR; Meyer zum Büschenfelde KH; Lohse AW
    J Hepatol; 1999 Oct; 31(4):635-40. PubMed ID: 10551386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The nature and prognostic implications of autoimmune hepatitis with an acute presentation.
    Nikias GA; Batts KP; Czaja AJ
    J Hepatol; 1994 Nov; 21(5):866-71. PubMed ID: 7890904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency and significance of antibodies to asialoglycoprotein receptor in type 1 autoimmune hepatitis.
    Czaja AJ; Pfeifer KD; Decker RH; Vallari AS
    Dig Dis Sci; 1996 Sep; 41(9):1733-40. PubMed ID: 8794787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to single-stranded and double-stranded DNA in antinuclear antibody-positive type 1-autoimmune hepatitis.
    Czaja AJ; Morshed SA; Parveen S; Nishioka M
    Hepatology; 1997 Sep; 26(3):567-72. PubMed ID: 9303484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of HLA DR4 in type 1 autoimmune hepatitis.
    Czaja AJ; Carpenter HA; Santrach PJ; Moore SB
    Gastroenterology; 1993 Nov; 105(5):1502-7. PubMed ID: 8224654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained remission after corticosteroid therapy of severe hepatitis B surface antigen-negative chronic active hepatitis.
    Czaja AJ; Beaver SJ; Shiels MT
    Gastroenterology; 1987 Jan; 92(1):215-9. PubMed ID: 3781190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics and corticosteroid therapy in patients with autoimmune-hepatitis-induced liver failure.
    Zhu B; You SL; Wan ZH; Liu HL; Rong YH; Zang H; Xin SJ
    World J Gastroenterol; 2014 Jun; 20(23):7473-9. PubMed ID: 24966618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency and nature of the variant syndromes of autoimmune liver disease.
    Czaja AJ
    Hepatology; 1998 Aug; 28(2):360-5. PubMed ID: 9695997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.